Plus Therapeutics reported $-4.4M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Baxter International USD 309M 756M Mar/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Haemonetics USD 96.17M 91.87M Jun/2026
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Sanofi EUR 3.69B 375M Jun/2026
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026